login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
APTEVO THERAPEUTICS INC (APVO) Stock News
USA
- NASDAQ:APVO -
US03835L5049
-
Common Stock
1.43
USD
+0.02 (+1.42%)
Last: 11/5/2025, 8:00:00 PM
1.44
USD
+0.01 (+0.7%)
Pre-Market:
11/6/2025, 6:31:21 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
APVO Latest News, Press Relases and Analysis
All
Press Releases
a month ago - By: ACCESS Newswire
Aptevo Presenting Scientific and Clinical Updates at SITC and ASH, also Participating in Leading Financial and Industry Conferences in the Fourth Quarter
a month ago - By: Benzinga
- Mentions:
SNWV
CLRB
SPRB
GLTO
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
2 months ago - By: ACCESS Newswire
Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML
3 months ago - By: ACCESS Newswire
Aptevo Highlights APVO442, a CD3-Directed Preclinical Candidate for Prostate Cancer
3 months ago - By: The Motley Fool
Aptevo Reports 85% Remission in Q2
a month ago - By: Benzinga
- Mentions:
SNWV
ONMD
GLMD
PCSA
...
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
3 months ago - By: ACCESS Newswire
Aptevo Therapeutics Reports 2Q25 Financial Results And Provides A Business Update
2 months ago - By: Stocktwits
Aptevo Therapeutics Stock Rallies On 100% Remission Rate In Acute Myeloid Leukemia Trial Cohort
2 months ago - By: ACCESS Newswire
- Mentions:
FMST
Foremost Clean Energy and Aptevo Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
2 months ago - By: ACCESS Newswire
Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules
3 months ago - By: ACCESS Newswire
- Mentions:
SXTP
Aptevo Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
4 months ago - By: Yahoo Finance
Aptevo Meets Nasdaq $2.5M Equity Requirement
5 months ago - By: ACCESS Newswire
Aptevo Therapeutics Announces Closing of $8 Million Offering Priced At-the-Market Under Nasdaq Rules
Please enable JavaScript to continue using this application.